Sofia Pazmino (E Buckinx)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Venues

Annals of the rheumatic diseases

RMD open

Rheumatology (Oxford, England)

The Journal of rheumatology

KU Leuven

Equinoctial Technological University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

KU Leuven Oct 01 2016

Belgium

PhD candidate :: Skeletal Biology and Engineering Research

Education History

Equinoctial Technological University - Apr 24 2014

Ecuador

PHD

Publications

Delphine Bertrand, Johan Joly, Barbara Neerinckx, Patrick Durez, Jan Lenaerts, Rik Joos, Kristof Thevissen, Tom Zwaenepoel, Johan Vanhoof, Silvana Di Romana, Veerle Taelman, Els Van Essche, Luk Corluy, Clio Ribbens, Marc Vanden Berghe, Mieke Devinck, Sofia Ajeganova, Anne Durnez, Yves Boutsen, Joëlle Margaux, Isabelle Peene, Jan Van Offel, Michaël Doumen, Sofia Pazmino, Elias De Meyst, Myroslava Kulyk, Nelly Creten, René Westhovens, Patrick Verschueren, null null
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial. RMD open 10 (3) (2024)
Alla Ishchenko, Sofia Pazmino, Barbara Neerinckx, Rik Lories, Kurt de Vlam
Comorbidities in early psoriatic arthritis: data from METAPSA cohort study. Arthritis care & research (2023)
Reem Assi, Chahrazad Cherifi, Frederique M F Cornelis, Qiongfei Zhou, Lies Storms, Sofia Pazmino, Rodrigo Coutinho de Almeida, Ingrid Meulenbelt, Rik Ju Lories, Silvia Monteagudo
Inhibition of KDM7A/B histone demethylases restores H3K79 methylation and protects against osteoarthritis. Annals of the rheumatic diseases (2023)
Michaël Doumen, Sofia Pazmino, Patrick Verschueren, René Westhovens
Viewpoint: Supporting mental health in the current management of rheumatoid arthritis: time to act! Rheumatology (Oxford, England) 62 (SI3) (2023)
Sofia Pazmino, Anikó Lovik, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, Michaël Doumen, Delphine Bertrand, René Westhovens, Patrick Verschueren
New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early Rheumatoid Arthritis. Rheumatology (Oxford, England) (2022)
Sofia Pazmino, Anikó Lovik, René Westhovens, Patrick Verschueren, null null
Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis Replication. The Journal of rheumatology 49 (4) (2022)
Sofia Pazmino, Patrick Verschueren, René Westhovens
JAK inhibition and the holy grail for pain control in early RA. RMD open 8 (1) (2022)
Sofia Pazmino, Rene Westhovens, Michaël Doumen, Delphine Bertrand, Patrick Verschueren
Undifferentiated arthritis, not just another early manifestation of rheumatoid arthritis. Rheumatology (Oxford, England) 61 (8) (2022)
Michaël Doumen, Sofia Pazmino, Delphine Bertrand, Diederik De Cock, Johan Joly, René Westhovens, Patrick Verschueren
Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response. Annals of the rheumatic diseases 81 (10) (2022)
Michaël Doumen, Diederik De Cock, Caroline Van Lierde, Albrecht Betrains, Sofia Pazmino, Delphine Bertrand, René Westhovens, Patrick Verschueren
Engagement and attrition with eHealth tools for remote monitoring in chronic arthritis: a systematic review and meta-analysis. RMD open 8 (2) (2022)
Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren
Response to: 'Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'' by Jain and Dhir et al. Annals of the rheumatic diseases (2021)
Veerle Stouten, René Westhovens, Diederik De Cock, Kristien Van der Elst, Sofia Pazmino, Delphine Bertrand, Johan Joly, Patrick Verschueren
Having a co-morbidity predicts worse outcome in early rheumatoid arthritis despite intensive treatment: a post hoc evaluation of the pragmatic randomized controlled CareRA trial. Rheumatology (Oxford, England) 60 (8) (2021)
Sofia Pazmino, Rene Westhovens, Diederik De Cock, Patrick Verschueren
Editorial commentary on: Prescribing anti-rheumatic drugs in pregnancy and breastfeeding-the BSR guideline scope. Rheumatology (Oxford, England) (2021)
Diederik De Cock, Sofia Pazmino, S Pazmino, Delphine Bertrand, Veerle Stouten, René Westhovens, Patrick Verschueren
Belgian rheumatologists' preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study. Rheumatology international (2021)
Michaël Doumen, René Westhovens, Maryline Vandeputte, Rani Van Melder, Kristien Van der Elst, Sofia Pazmino, Delphine Bertrand, Veerle Stouten, Els Van Laeken, Nelly Creten, Claudia Neys, Patrick Verschueren, Diederik De Cock
The perception of stakeholders on the applicability of nurse-led clinics in the management of rheumatoid arthritis. Rheumatology advances in practice 5 (Suppl 2) (2021)
Veerle Stouten, Sofia Pazmino, Patrick Verschueren, Pavlos Mamouris, René Westhovens, Kurt de Vlam, Delphine Bertrand, Kristien Van der Elst, Bert Vaes, Diederik De Cock
Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study. RMD open 7 (2) (2021)
Michaël Doumen, Diederik De Cock, Sofia Pazmino, Delphine Bertrand, Johan Joly, René Westhovens, Patrick Verschueren
Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well-Being and Disease Activity. Arthritis care & research (2021)
Sofia Pazmino, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, Delphine Bertrand, René Westhovens, Patrick Verschueren
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial. RMD open 7 (2) (2021)
Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren
Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial. Annals of the rheumatic diseases (2021)
Sofia Pazmino, Anikó Lovik, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, Delphine Bertrand, Kristien Van der Elst, Rene Westhovens, Patrick Verschueren
Does Including Pain, Fatigue, and Physical Function When Assessing Patients with Early Rheumatoid Arthritis Provide a Comprehensive Picture of Disease Burden? The Journal of rheumatology 48 (2) (2020)
Diederik De Cock, Isaline Soenen, Delphine Bertrand, Sofia Pazmino, Veerle Stouten, René Westhovens, Patrick Verschueren
Correspondence on 'EULAR recommendations for a core data set for pregnancy registries in rheumatology'. Annals of the rheumatic diseases (2020)
Sofia Pazmino, Annelies Boonen, Veerle Stouten, Diederik De Cock, Johan Joly, Kristien Van der Elst, Rene Westhovens, Patrick Verschueren
Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial. Annals of the rheumatic diseases 79 (5) (2020)

Sofia Pazmino.css-eqlu8i{font-size:small;padding-left:4px;} (E Buckinx)

Publication Activity (10 Years)

Top Topics

Top Venues

Sofia Pazmino (E Buckinx)